Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
WHO panel on the governance of gene editing
Minssen, Timo (Other)
2021Activity: Talk or presentation types › Lecture and oral contribution
Visit of Prof. Hisashi Urushihara, Division of Drug Development & Regulatory Science, Faculty of Pharmacy, Keio University, DK/JP cooperation in health, regulatory sciences & clinical development
Minssen, Timo (Organizer)
6 Mar 2019Activity: Participating in an event - types › Participation in workshop, seminar, course
Virtual INAMRSS meeting at CeBIL
Minssen, Timo (Participant) & Minssen, Timo (Organizer)
1 Dec 2020Activity: Participating in an event - types › Organisation of and participation in conference
Utility Model Protection in Danish Law at LSE
Minssen, Timo (Other)
2 Feb 2023Activity: Talk or presentation types › Lecture and oral contribution
Use of Data and Research, the EHDS, the EOSC, and the Legal Interoperability of FAIR Data
Minssen, Timo (Speaker) & Corrales Compagnucci, Marcelo (Participant)
15 Nov 2021Activity: Participating in an event - types › Participation in workshop, seminar, course
University of Oxford
Minssen, Timo (Visiting researcher)
Mar 2014 → Jun 2014Activity: Visiting an external institution types › Visiting an external academic institution
University of Cambridge
Minssen, Timo (Visiting researcher)
Oct 2016 → Dec 2016Activity: Visiting an external institution types › Visiting an external academic institution
University of Cambridge
Minssen, Timo (Visiting researcher)
Sep 2016 → Dec 2016Activity: Visiting an external institution types › Visiting an external academic institution
US decisions in Sequenom Inc v Ariosa Diagnostics Inc- What now?: University of Cambridge (UK)
Minssen, Timo (Invited speaker)
6 Sep 2016Activity: Talk or presentation types › Lecture and oral contribution
U.S. regulation and patentability of human embryonic stem cell research
Minssen, Timo (Speaker)
21 Mar 2012Activity: Talk or presentation types › Lecture and oral contribution
ID: 16150437
Most downloads
-
4331
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2203
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2080
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published